394 related articles for article (PubMed ID: 30115017)
1. Lesions of "uncertain malignant potential" in the breast (B3) identified with mammography screening.
Richter-Ehrenstein C; Maak K; Röger S; Ehrenstein T
BMC Cancer; 2018 Aug; 18(1):829. PubMed ID: 30115017
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening.
El-Sayed ME; Rakha EA; Reed J; Lee AH; Evans AJ; Ellis IO
Histopathology; 2008 Dec; 53(6):650-7. PubMed ID: 19076681
[TBL] [Abstract][Full Text] [Related]
3. Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening.
Rakha EA; Lee AH; Jenkins JA; Murphy AE; Hamilton LJ; Ellis IO
Int J Cancer; 2011 Sep; 129(6):1417-24. PubMed ID: 21128240
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous risk profiles among B3 breast lesions of uncertain malignant potential.
Orsaria P; Grasso A; Carino R; Caredda E; Sammarra M; Altomare C; Rabitti C; Gullotta G; Perrone G; Pantano F; Buonomo OC; Altomare V
Tumori; 2020 Apr; 106(2):115-125. PubMed ID: 31451072
[TBL] [Abstract][Full Text] [Related]
5. Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).
Elfgen C; Leo C; Kubik-Huch RA; Muenst S; Schmidt N; Quinn C; McNally S; van Diest PJ; Mann RM; Bago-Horvath Z; Bernathova M; Regitnig P; Fuchsjäger M; Schwegler-Guggemos D; Maranta M; Zehbe S; Tausch C; Güth U; Fallenberg EM; Schrading S; Kothari A; Sonnenschein M; Kampmann G; Kulka J; Tille JC; Körner M; Decker T; Lax SF; Daniaux M; Bjelic-Radisic V; Kacerovsky-Strobl S; Condorelli R; Gnant M; Varga Z
Virchows Arch; 2023 Jul; 483(1):5-20. PubMed ID: 37330436
[TBL] [Abstract][Full Text] [Related]
6. Value of Long-term Follow-up in Surgically Excised Lesions of Uncertain Malignant Potential in the Breast - Is 5 Years Necessary?
Hennessy G; Boland MR; Bambrick M; Crone L; Lloyd A; Abdelwahab S; Downey E; Staunton M; Hambly N; Mhuircheartaigh NN; Kerr J; Power C; Duke D; Hill AD
Clin Breast Cancer; 2022 Oct; 22(7):699-704. PubMed ID: 35732544
[TBL] [Abstract][Full Text] [Related]
7. Correlation of needle core biopsy with excision histology in screen-detected B3 lesions: the Merrion Breast Screening Unit experience.
Hayes BD; O'Doherty A; Quinn CM
J Clin Pathol; 2009 Dec; 62(12):1136-40. PubMed ID: 19946101
[TBL] [Abstract][Full Text] [Related]
8. Outcome of breast lesions diagnosed as lesion of uncertain malignant potential (B3) or suspicious of malignancy (B4) on needle core biopsy, including detailed review of epithelial atypia.
Rakha EA; Ho BC; Naik V; Sen S; Hamilton LJ; Hodi Z; Ellis IO; Lee AH
Histopathology; 2011 Mar; 58(4):626-32. PubMed ID: 21371081
[TBL] [Abstract][Full Text] [Related]
9. The Upgrade Risk of B3 Lesions to (Pre)Invasive Breast Cancer After Diagnosis on Core Needle or Vacuum Assisted Biopsy. A Belgian National Cohort Study.
Willers N; Neven P; Floris G; Colpaert C; Oldenburger E; Han S; Van Ongeval C; Smeets A; Duhoux FP; Wildiers H; Denolf P; Laudus N; Dequeker E; De Brabander I; Van Damme N; De Schutter H
Clin Breast Cancer; 2023 Jun; 23(4):e273-e280. PubMed ID: 37085379
[TBL] [Abstract][Full Text] [Related]
10. Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3).
Lee AH; Denley HE; Pinder SE; Ellis IO; Elston CW; Vujovic P; Macmillan RD; Evans AJ;
Histopathology; 2003 Apr; 42(4):331-6. PubMed ID: 12653944
[TBL] [Abstract][Full Text] [Related]
11. Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended?
Lucioni M; Rossi C; Lomoro P; Ballati F; Fanizza M; Ferrari A; Garcia-Etienne CA; Boveri E; Meloni G; Sommaruga MG; Ferraris E; Lasagna A; Bonzano E; Paulli M; Sgarella A; Di Giulio G
Eur Radiol; 2021 Feb; 31(2):920-927. PubMed ID: 32816199
[TBL] [Abstract][Full Text] [Related]
12. Flat epithelial atypia is a common subtype of B3 breast lesions and is associated with noninvasive cancer but not with invasive cancer in final excision histology.
Noske A; Pahl S; Fallenberg E; Richter-Ehrenstein C; Buckendahl AC; Weichert W; Schneider A; Dietel M; Denkert C
Hum Pathol; 2010 Apr; 41(4):522-7. PubMed ID: 20004938
[TBL] [Abstract][Full Text] [Related]
13. Absence of epithelial atypia in B3-lesions of the breast is associated with decreased risk for malignancy.
Mayer S; Kayser G; Rücker G; Bögner D; Hirschfeld M; Hug C; Stickeler E; Gitsch G; Erbes T
Breast; 2017 Feb; 31():144-149. PubMed ID: 27866089
[TBL] [Abstract][Full Text] [Related]
14. Borderline breast core needle histology: predictive values for malignancy in lesions of uncertain malignant potential (B3).
Houssami N; Ciatto S; Bilous M; Vezzosi V; Bianchi S
Br J Cancer; 2007 Apr; 96(8):1253-7. PubMed ID: 17438578
[TBL] [Abstract][Full Text] [Related]
15. The positive predictive value of vacuum assisted biopsy (VAB) in predicting final histological diagnosis for breast lesions of uncertain malignancy (B3 lesions): A systematic review & meta-analysis.
Cullinane C; Byrne J; Kelly L; O Sullivan M; Antony Corrigan M; Paul Redmond H
Eur J Surg Oncol; 2022 Jul; 48(7):1464-1474. PubMed ID: 35491362
[TBL] [Abstract][Full Text] [Related]
16. Our Radiological Experience on B3 Lesions: Correlation Between Mammographic and MRI Findings With Histologic Definitive Result.
Santucci D; Faiella E; Calabrese A; Favale L; Zobel BB; de Felice C
Clin Breast Cancer; 2019 Oct; 19(5):e643-e653. PubMed ID: 31377083
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of breast lesions of "uncertain malignant potential" and "suspicious for malignancy" determined by needle core biopsy.
Dillon MF; McDermott EW; Hill AD; O'Doherty A; O'Higgins N; Quinn CM
Ann Surg Oncol; 2007 Feb; 14(2):704-11. PubMed ID: 17151788
[TBL] [Abstract][Full Text] [Related]
18. Pure flat epithelial atypia (DIN 1a) on core needle biopsy: study of 60 biopsies with follow-up surgical excision.
Lavoué V; Roger CM; Poilblanc M; Proust N; Monghal-Verge C; Sagan C; Tas P; Mesbah H; Porée P; Gay C; Body G; Levêque J
Breast Cancer Res Treat; 2011 Jan; 125(1):121-6. PubMed ID: 20945087
[TBL] [Abstract][Full Text] [Related]
19. Role of vacuum assisted excision in minimising overtreatment of ductal atypias.
McMahon MA; Haigh I; Chen Y; Millican-Slater RA; Sharma N
Eur J Radiol; 2020 Oct; 131():109258. PubMed ID: 32919262
[TBL] [Abstract][Full Text] [Related]
20. Will the spectrum of lesions prompting a "B3" breast core biopsy increase the benign biopsy rate?
Carder PJ; Liston JC
J Clin Pathol; 2003 Feb; 56(2):133-8. PubMed ID: 12560393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
